Genetics and Brain Ischemia in the Critically Ill

危重病人的遗传学和脑缺血

• 批准号: 6738068
• 负责人: Mary E. Kerr
• 金额: $ 10.16万
• 依托单位: UNIVERSITY OF PITTSBURGH AT PITTSBURGH
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-06-01 至 2005-02-04
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6738068
• 关键词: brain circulation; brain injury; brain metabolism; cerebral ischemia /hypoxia; cerebrospinal fluid; clinical research; gene deletion mutation; genetic screening; genetic susceptibility; glucose transport; human mortality; human subject; human therapy evaluation; human tissue; longitudinal human study; mitochondrial DNA; nervous system disorder diagnosis; nervous system disorder therapy; neurogenetics; oxygen transport; patient oriented research; perfusion; postmortem

DESCRIPTION (provided by applicant): This K24 Midcareer Investigator application describes the investigator's dedication to patient-oriented research, her experience in mentoring young researchers, and how this award would consolidate and develop these career commitments. The clinical focus of this application is the identification of genetic factors that will maximize cerebral perfusion in the critically ill patient with brain injury. The specific aims for this study are to: 1) describe the incidence of two common mitochondrial DNA (mtDNA) deletions (4799bp and 7436 bp) found in the cerebrospinal fluid (CSF) within the acute phase following brain injury; 2) determine whether the presence of mtDNA deletions are associated with cerebral profusion and metabolism and; 3) determine whether mtDNA deletions are associated with outcomes [Glasgow Outcomes Scale (GOS) and morality]. A descriptive comparative design will be used to determine whether the presence of mtDNA deletions decreases cerebral blood flow (CBF) and metabolism and results in poorer outcomes in critically ill brain injured patients. Two currently funded clinical research projects [Methods of Predicting Delayed Cerebral lschemia in Subarahnoid Hemorrhage, and The Effect of ApoE Genotype on Outcomes in Traumatic Brain Injured Adults] will provide the foundation for the mentoring activities that will enhance and develop young investigators' clinical research skills. They will also provide patient data on the timing, severity, type, and location of insult, demographic information, CSF for analysis, CBF and ischemia data, physiologic parameters and outcome evaluation. The long-term career objective is to identify profiles of patients based on genetic variation that will allow clinicians to design individualized interventions to maximize cerebral perfusion. The focus of inter-individual variations of patients with a severe brain injury will provide the opportunity to educate and mentor junior clinical investigators in the design, implementation, evaluation and dissemination of clinical studies that will, in the long term, improve patient outcomes. The studies are designed as a combination of basic and clinical science in order to directly apply the results to clinical practice. The incorporation of an individual' s genetic profile for maximizing cerebral perfusion provides an excellent platform for training the next generation of patient-oriented critical care researchers.

描述（由申请人提供）：此K24中期职业研究者申请描述了研究者对以患者为导向的研究的奉献精神，她在指导年轻研究人员方面的经验，以及该奖项将如何巩固和发展这些职业承诺。该应用的临床重点是识别将最大化脑损伤危重患者脑灌注的遗传因素。本研究的具体目的是：1）描述两种常见的线粒体DNA（mtDNA）缺失的发生率（2）确定脑损伤后急性期脑脊液中mtDNA缺失（4799 bp和7436 bp）的存在是否与脑灌注和代谢有关; 3）确定mtDNA缺失是否与结局[格拉斯哥结局量表（GOS）和死亡率]相关。 将使用描述性比较设计来确定mtDNA缺失的存在是否会降低脑血流量（CBF）和代谢，并导致危重脑损伤患者的预后较差。目前资助的两个临床研究项目[预测蛛网膜下腔出血中迟发性脑缺血的方法和ApoE基因型对创伤性脑损伤成人结局的影响]将为指导活动提供基础，这些活动将增强和发展年轻研究人员的临床研究技能。他们还将提供有关损伤时间、严重程度、类型和位置的患者数据、人口统计学信息、用于分析的CSF、CBF和缺血数据、生理参数和结局评价。长期的职业目标是根据遗传变异识别患者的特征，这将使临床医生能够设计个性化的干预措施，以最大限度地提高脑灌注。关注严重脑损伤患者的个体间差异将为初级临床研究者提供教育和指导的机会，指导他们设计、实施、评估和传播临床研究，从长远来看，这些研究将改善患者结局。这些研究被设计为基础和临床科学的结合，以便将结果直接应用于临床实践。将个体的遗传特征纳入脑灌注最大化，为培养下一代以患者为导向的重症监护研究人员提供了一个很好的平台。